Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04564898
Title Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients. (TriComB)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Gruppo Oncologico del Nord-Ovest
Indications

colorectal cancer

Therapies

Bevacizumab + Capecitabine + Trifluridine-tipiracil hydrochloride

Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.